• facebook
  • nasaba
  • youtube

Bambancin Omicron: Abin da Kuna Bukatar Sanin
Bayani game da Bambance-bambance: ƙwayoyin cuta koyaushe suna canzawa ta hanyar maye gurbi kuma wani lokacin waɗannan maye gurbi suna haifar da sabon nau'in ƙwayar cuta.Wasu bambance-bambancen suna fitowa kuma suna ɓacewa yayin da wasu suka dawwama.Sabbin bambance-bambancen za su ci gaba da fitowa.CDC da sauran kungiyoyin kiwon lafiyar jama'a suna sa ido kan kowane nau'in kwayar cutar da ke haifar da COVID-19 a cikin Amurka da duniya.

Bambancin Delta yana haifar da ƙarin cututtuka kuma yana yaduwa cikin sauri fiye da nau'in ƙwayar cuta ta SARS-CoV-2 wacce ke haifar da COVID-19.Alurar riga kafi sun kasance hanya mafi kyau don rage haɗarin rashin lafiya mai tsanani, asibiti, da mutuwa daga COVID-19.

Manyan Abubuwan Da Ya Kamata Ku Sani
1.Sabbin bambance-bambancen kwayar cutar ana sa ran faruwa.Ɗaukar matakai don rage yaduwar kamuwa da cuta, gami da samun rigakafin COVID-19, shine hanya mafi kyau don sassauta bullar sabbin bambance-bambancen.
2.Alurar rigakafi suna rage haɗarin kamuwa da cuta mai tsanani, asibiti, da mutuwa daga COVID-19.
3. An ba da shawarar allurai masu ƙarfafa COVID-19 ga manya masu shekaru 18 da haihuwa.Matasa masu shekaru 16-17 da suka karɓi Pfizer-BioNTech COVID-19 alluran rigakafin za su iya samun ƙarin kashi idan sun kasance aƙalla watanni 6 bayan jerin allurar rigakafin Pfizer-BioNTech na farko.

Magungunan rigakafi
Yayin da alluran rigakafi suna rage haɗarin ku na rashin lafiya mai tsanani, asibiti, da mutuwa daga COVID-19, har yanzu ba mu san yadda tasirin su zai yi da sabbin bambance-bambancen da za su iya tasowa ba, gami da Omicron.
huhu virus haske icon
Alamun
Duk bambance-bambancen da suka gabata suna haifar da alamun COVID-19 iri ɗaya.
Wasu bambance-bambancen, irin su bambance-bambancen Alpha da Delta, na iya haifar da ƙarin rashin lafiya da mutuwa.
alamar haske gefen abin rufe fuska
Masks
Sanya abin rufe fuska hanya ce mai inganci don rage yaduwar nau'ikan kwayar cutar a baya, bambance-bambancen Delta da sauran bambance-bambancen da aka sani.
Mutanen da ba su da cikakkiyar rigakafin ya kamata su ɗauki matakai don kare kansu, gami da sanya abin rufe fuska a cikin gida a cikin jama'a a duk matakan watsawar al'umma.
Mutanen da ke da cikakkiyar alurar riga kafi yakamata su sanya abin rufe fuska a cikin gida a wuraren da ake yaduwa mai yawa ko babba.
Sanya abin rufe fuska yana da matukar mahimmanci idan kai ko wani a cikin gidan ku
Yana da raunin garkuwar jiki
Yana da yanayin rashin lafiya
Baligi ne babba
Ba a yi cikakken alurar riga kafi ba
Gwaji
Gwaje-gwaje na SARS-CoV-2 suna gaya muku idan kuna da kamuwa da cuta a lokacin gwajin.Irin wannan gwajin ana kiransa gwajin “viral” saboda yana neman kamuwa da cuta.Antigen ko Nucleic Acid Amplification Tests (NAATs) gwaje-gwaje ne na kwayar cuta.
Ana buƙatar ƙarin gwaje-gwaje don sanin ko wane bambance-bambancen ne ya haifar da kamuwa da cuta, amma waɗannan yawanci ba su da izini don amfani da haƙuri.
Yayin da sabbin bambance-bambancen ke fitowa, masana kimiyya za su ci gaba da kimanta yadda gwaje-gwaje ke gano kamuwa da cuta na yanzu.
Ana iya amfani da gwaje-gwajen kai idan kana da alamun COVID-19 ko kuma an fallasa su ko yuwuwar fallasa ga mutum mai COVID-19.
Ko da ba ku da alamun cutar kuma ba a fallasa ku ga mutumin da ke da COVID-19, yin amfani da gwajin kai kafin haɗuwa a gida tare da wasu na iya ba ku bayani game da haɗarin yada kwayar cutar da ke haifar da COVID-19.
Nau'in Bambance-bambance
Masana kimiyya suna lura da duk bambance-bambancen amma suna iya rarraba wasu a matsayin bambance-bambancen da ake sa ido, bambance-bambancen ban sha'awa, bambance-bambancen damuwa da bambance-bambancen sakamako mai girma.Wasu bambance-bambancen suna bazuwa cikin sauƙi da sauri fiye da sauran bambance-bambancen, wanda zai iya haifar da ƙarin lokuta na COVID-19.Ƙara yawan lokuta zai sanya ƙarin damuwa akan albarkatun kiwon lafiya, haifar da ƙarin asibiti, da yiwuwar ƙarin mutuwa.
Waɗannan rarrabuwa sun dogara ne akan yadda bambance-bambancen ke yaɗuwa cikin sauƙi, yadda alamun alamun suka yi tsanani, yadda bambance-bambancen ke amsa jiyya, da kuma yadda rigakafin ke ba da kariya daga bambance-bambancen.
Bambance-bambancen Damuwa

Damuwa1

Omicron - B.1.1.529
Farkon gano: Afirka ta Kudu
Yaduwa: Zai iya yaduwa cikin sauƙi fiye da sauran bambance-bambancen, gami da Delta.
Mummunan rashin lafiya da mutuwa: Saboda ƙarancin adadin lokuta, tsananin rashin lafiya da mutuwar da ke tattare da wannan bambance-bambancen ba su da tabbas.
Alurar riga kafi: Ana sa ran ci gaba da kamuwa da cuta a cikin mutanen da suka yi cikakken alurar riga kafi, amma alluran rigakafi suna da tasiri wajen hana rashin lafiya mai tsanani, asibiti, da mutuwa.Bayanan farko sun nuna cewa mutanen da ke da cikakken alurar riga kafi waɗanda suka kamu da bambance-bambancen Omicron na iya yada cutar ga wasu.Duk magungunan da FDA ta amince da su ko izini ana tsammanin suyi tasiri akan rashin lafiya mai tsanani, asibiti, da mutuwa.Fitowar Omicron na baya-bayan nan yana ƙara jaddada mahimmancin allurar rigakafi da ƙarfafawa.
Jiyya: Wasu jiyya na rigakafin ƙwayoyin cuta na monoclonal ƙila ba su da tasiri a kan kamuwa da Omicron.

Damuwa2

Delta - B.1.617.2
An fara gano shi: Indiya
Yada: Yana yaduwa cikin sauƙi fiye da sauran bambance-bambancen.
Mummunan rashin lafiya da mutuwa: Yana iya haifar da lokuta masu tsanani fiye da sauran bambance-bambancen
Alurar riga kafi: Ana sa ran ci gaba da kamuwa da cuta a cikin mutanen da suka yi cikakken alurar riga kafi, amma alluran rigakafi suna da tasiri wajen hana rashin lafiya mai tsanani, asibiti, da mutuwa.Bayanai na farko sun nuna cewa mutanen da ke da cikakken alurar riga kafi da suka kamu da bambance-bambancen Delta na iya yada cutar ga wasu.Duk magungunan da FDA ta amince da su ko izini suna da tasiri a kan rashin lafiya mai tsanani, asibiti, da mutuwa.
Jiyya: Kusan duk bambance-bambancen da ke yawo a cikin Amurka suna amsa jiyya tare da izinin maganin rigakafin mutum guda ɗaya na FDA.
Source: https://www.cdc.gov/coronavirus/2019-ncov/variants/about-variants.html

Samfura masu dangantaka:
https://www.foreivd.com/sars-cov-2-variant-nucleic-acid-detection-kit-ii-multiplex-pcr-fluorescent-probe-method-product/
https://www.foreivd.com/sample-release-agent-product/


Lokacin aikawa: Janairu-21-2022